 |
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2016, vol. 22, issue 1
Subject Area: Medicine
Pages: 1067-1071
DOI: 10.5272/jimab.2016221.1067
Published online: 22 March 2016
J of IMAB 2016 Jan-Mar;22(1):1067-1071
CONTAMINATED PROBLEMATIC SKIN WOUNDS IN DIABETIC PATIENTS TREATED WITH AUTOLOGOUS PLATELET-RICH PLASMA (PRP): A case series study
Tsvetan Sokolov, 
, Boyan Valentinov, Jordan Andonov, Sevdalin Angelov, Pencho Kosev
Department of Orthopedics and Traumatology, MHAT Rousse, Rousse, Bulgaria.
ABSTRACT:
OBJECTIVE: To study the effect of platelet-rich plasma (PRP) on contaminated problematic skin ulcers in patients with diabetes.
MATERIAL AND METHODS: A total of 6 patients had been treated within the period from 2012 to 2014; they had various types of problematic wounds and diabetes type 2. Patients’ distribution by sex was as follows: 1 man and 5 women; mean age- 68 years. Ulcer types: acute (2 patients), hard-to-heal (2 patients) and chronic (2 patients) ulcers. The mean size of the skin and soft tissue defect was 9,5 cm2. Pathogenic microflora was isolated in 4 patients - S. aureus in three and Е. Coli in one. Based on a scheme developed by us, all cases were treated by administering platelet-rich plasma, derived by PRGF Endoret system. Follow-up period was within 4 – 6 months (4,5 on average). We used platelet rich plasma derived by PRGF Endoret system, applied on the wound bed on a weekly basis.
RESULTS: Application of PRP allowed successful closure of all wounds. There were no complications associated with treatment of PRP. Epithelialization of the wound took 15 weeks on average for all patients. One patient presented with hyperkeratosis. Initial score of followed wounds, based on the scales are as follows: Total wound score – 10 p. Total anatomic score – 8 p. Total score – 15 p. at the initial stage. At the end of the treatment period scores were as follows - 0 p., which means excellent results
CONCLUSION: We believe that the application of PRP may become optimal therapy in the treatment of contaminated problematic wounds in diabetic patients. PRP not only stimulates wound healing, but also has antimicrobial properties, which may contribute to the prevention of infections..
Key words: problematic skin wounds, platelet rich plasma, functional scoring scales,
- Download FULL TEXT /PDF 975 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Sokolov T, Valentinov B, Andonov J, Angelov S, Kosev P. Contaminated problematic skin wounds in diabetic patients treated with autologous platelet - rich plasma (PRP): A case series study. J of IMAB. 2016 Jan-Mar;22(1):1063-1066. DOI: http://dx.doi.org/10.5272/jimab.2016221.1067.
Correspondence to: D-r Tsvetan Sokolov, Department of Orthopedics and Traumatology, MHAT- Ruse, Ruse, Bulgaria; 2, Nezavisimost str., 7002 Ruse, Bulgaria; E-mail: sokolovi2001@abv.bg
REFERENCES:
1. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004 Apr;30(2):145-151. [PubMed] [CrossRef]
2. Lana JF, Weglein A, Vicente E, Perez AG, Rodrigues A, Luzo AC, et al. Platelet Rich Plasma and Its Growth Factors: The State of the Art. In: Lana JF, et al. (eds.), Platelet-Rich Plasma. Lecture Notes in Bioengineering. Springer-Verlag Berlin, Heidelberg. 2014; p1-59.
3. Cugat R. Front Matter: Foreword I. In: Lana JF, et al. (eds.), Platelet- Rich Plasma. Regenerative Medicine: Sports Medicine, Orthopedic, and Recovery of Musculoskeletal Injuries. Springer-Verlag Berlin, Heidelberg. 2014; p v-vi.
4. Frank C, Bayoumi I, Westendorp C . Approach to infected skin ulcers. Can Fam Physician. 2005 Oct;51:1352-1359. [PubMed]
5. Sibbald RG, Contreras-Ruiz J, Coutts P, Fierheller M, Rothman A, Woo K. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Adv Skin Wound Care. 2007 Oct;20(10):549-558. [PubMed] [CrossRef]
6. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 2008 Jan-Feb;16(1):2-10. [PubMed] [CrossRef]
7. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004; 187:65-70. [PubMed] [CrossRef]
8. Cancela AM, Lana JF, Annichino-Bizzachi JM, Belangero WD, Luzo ACM. Use of Platelet-Rich Plasma (PRP) in Treating Chronic Wounds. In: Lana JF, et al. (eds.), Platelet-Rich Plasma. Lecture Notes in Bioengineering. Springer-Verlag Berlin, Heidelberg. 2014; p 281-288. [CrossRef].
9. Bowling FL, Rashid ST, Boulton AJ. Preventing and treating foot complications associated with diabetes mellitus. Nat Rev Endocrinol. 2015 Oct;11(10):606-616. [PubMed] [CrossRef]
10. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag. 2007; 3(1): 65-76. [PubMed]
11. Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas A, Orive G, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater.2008 Feb;84(2):415-421. [PubMed] [CrossRef]
12. Alexiadou K, Doupis J. Management of Diabetic Foot Ulcers. Diabetes Ther. 2012 Dec;3(1):4. [PubMed] [CrossRef]
13. Wang G. Human Antimicrobial Peptides and Proteins. Pharmaceuticals (Basel). 2014 May;7(5):545-594. [PubMed] [CrossRef]
14. Tohidnezhad M, Varoga D, Podschun R, Wruck CJ, Seekamp A, Brandenburget LO, et al. Thrombocytes are effectors of the innate immune system releasing human beta defensin-3. Injury. 2011 Jul;42(7):682-686. [PubMed] [CrossRef]
15. Bielecki T, Gazdzik TS, Szczepanski T. Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur Surg Res. 2008; 40(3):289-296. [PubMed] [CrossRef]
16. Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008 Mar;26(3):404-410. [PubMed] [CrossRef]
17. Margolis DJ, Kantor J, Santanna J. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care.2001;24(3):483–488.
18. Anitua E, Alonso R, Girbau C, Aguirre J, Muruzabal F, et al. Antibacterial effect of plasma rich in growth factors (PRGF-Endoret) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol. 2012 Aug;37(6):652-7. [PubMed] [CrossRef].
Received: 18 January 2016
Published online: 22 March 2016